Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts

医学 免疫检查点 细胞毒性T细胞 彭布罗利珠单抗 肿瘤微环境 无容量 免疫疗法 癌症研究 CD8型 免疫系统 癌症免疫疗法 封锁 生物 T细胞 免疫学 受体 遗传学 体外
作者
Michele Bortolomeazzi,Mohamed Reda Keddar,Lucia Montorsi,Amelia Acha‐Sagredo,Lorena Gabriela Benedetti,Damjan Temelkovski,Subin Choi,Nedyalko Petrov,Katrina Todd,Patty T. Wai,Johannes Kohl,Tamara Denner,Emma L. Nye,Robert J. Goldstone,Sophia Ward,Gareth A. Wilson,Maise Al Bakir,Charles Swanton,Susan John,James Miles
出处
期刊:Gastroenterology [Elsevier BV]
卷期号:161 (4): 1179-1193 被引量:147
标识
DOI:10.1053/j.gastro.2021.06.064
摘要

Background & Aims Colorectal cancer (CRC) shows variable response to immune checkpoint blockade, which can only partially be explained by high tumor mutational burden (TMB). We conducted an integrated study of the cancer tissue and associated tumor microenvironment (TME) from patients treated with pembrolizumab (KEYNOTE 177 clinical trial) or nivolumab to dissect the cellular and molecular determinants of response to anti- programmed cell death 1 (PD1) immunotherapy. Methods We selected multiple regions per tumor showing variable T-cell infiltration for a total of 738 regions from 29 patients, divided into discovery and validation cohorts. We performed multiregional whole-exome and RNA sequencing of the tumor cells and integrated these with T-cell receptor sequencing, high-dimensional imaging mass cytometry, detection of programmed death-ligand 1 (PDL1) interaction in situ, multiplexed immunofluorescence, and computational spatial analysis of the TME. Results In hypermutated CRCs, response to anti-PD1 immunotherapy was not associated with TMB but with high clonality of immunogenic mutations, clonally expanded T cells, low activation of Wnt signaling, deregulation of the interferon gamma pathway, and active immune escape mechanisms. Responsive hypermutated CRCs were also rich in cytotoxic and proliferating PD1 + CD8 T cells interacting with PDL1 + antigen-presenting macrophages. Conclusions Our study clarified the limits of TMB as a predictor of response of CRC to anti-PD1 immunotherapy. It identified a population of antigen-presenting macrophages interacting with CD8 T cells that consistently segregate with response. We therefore concluded that anti-PD1 agents release the PD1-PDL1 interaction between CD8 T cells and macrophages to promote cytotoxic antitumor activity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
red_butterfly发布了新的文献求助10
1秒前
Zhangtao完成签到,获得积分0
2秒前
传奇3的应助被上山打老虎采纳,获得10
2秒前
3秒前
与风同行完成签到 ,获得积分10
4秒前
慎独的应助被zzz采纳,获得10
5秒前
5秒前
小公完成签到,获得积分10
5秒前
zzzz完成签到,获得积分20
5秒前
沉默完成签到,获得积分10
5秒前
whtestar完成签到,获得积分10
6秒前
zzy完成签到,获得积分10
6秒前
123完成签到,获得积分10
6秒前
6秒前
壮观的哈密瓜完成签到,获得积分10
7秒前
xiaobai发布了新的文献求助10
9秒前
xcgh的应助被sunny采纳,获得10
10秒前
传奇3的应助被小公采纳,获得10
10秒前
knn完成签到,获得积分10
10秒前
CipherSage的应助被变形金刚采纳,获得10
10秒前
10秒前
羞涩的寒风完成签到,获得积分10
12秒前
camellia发布了新的文献求助10
12秒前
上山打老虎完成签到,获得积分10
13秒前
李健的应助被绿鲤鱼采纳,获得10
13秒前
充电宝的应助被luyu采纳,获得10
13秒前
所所的应助被kjwu采纳,获得10
13秒前
13秒前
seeker完成签到,获得积分10
14秒前
情怀的应助被IneedPdh采纳,获得10
14秒前
coast完成签到 ,获得积分10
15秒前
15秒前
16秒前
LAN完成签到,获得积分10
16秒前
16秒前
16秒前
16秒前
追佩奇十条街完成签到 ,获得积分10
16秒前
16秒前
wanci的应助被sun采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185975
求助须知:如何正确求助?哪些是违规求助? 9574573
关于积分的说明 21836876
捐赠科研通 7783711
什么是DOI,文献DOI怎么找? 3434701
关于科研通互助平台的介绍 2559031
邀请新用户注册赠送积分活动 2481484